SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-046324
Filing Date
2012-08-15
Accepted
2012-08-15 16:09:03
Documents
5
Period of Report
2012-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v321637_8k.htm 8-K 14993
2 EXHIBIT 10.1 v321637_ex10-1.htm EX-10.1 6428
3 EXHIBIT 10.2 v321637_ex10-2.htm EX-10.2 7490
4 GRAPHIC image_001.jpg GRAPHIC 4597
5 GRAPHIC image_002.jpg GRAPHIC 2684
  Complete submission text file 0001144204-12-046324.txt   40390
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13441 | Film No.: 121037218
SIC: 2836 Biological Products, (No Diagnostic Substances)